Form EFFECT Gossamer Bio, Inc.
| UNITED STATES | |
| SECURITIES AND EXCHANGE COMMISSION | |
| Washington, D.C. 20549 | |
| Notice of Effectiveness | |
| Effectiveness Date: | March 18, 2026 |
| Accession Number: | 0001728117-26-000020 | ||||||
| Submission Type: | POS AM | ||||||
| |||||||
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gossamer Bio exchange offer closes with $18.9M in notes remaining
- Australia's Drummond Capital Partners Secures Investment from Kudu Investment Management
- First Carolina Financial Services Rings NYSE Closing Bell to Celebrate Initial Public Offering
Create E-mail Alert Related Categories
SEC FilingsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!



Tweet
Share